Revolving Door: DEA ’s No.2 quits amid reports of previous consulting work for Big Pharma

The U.S. Drug Enforcement Administration’s second-in-command has quietly stepped down amid reporting by The Associated Press that he previously consulted for a pharmaceutical distributor sanctioned for a deluge of suspicious painkiller shipments and did similar work for the drugmaker that became…

Source: Reuters: Health - July 19, 2023 Category: Consumer Health News Source Type: news